Human Antibodies Against Severe Acute Respiratory Syndrome Coronavirus-2 (Sars-Cov-2)

text

Inventors

Stefan Moese, Nike Kräutler, Cédric Cortijo, Jan Grimm, Benoit Combaluzier, Roger Nitsch, Christoph Hock

Assignees

  1. Neurimmune Ag

Abstract

Provided are novel human-derived monoclonal antibodies as well as antigen-binding fragments thereof which specifically recognize and preferably neutralize severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The anti-SARS-CoV-2 antibodies provided herein are useful in treating and diagnosis of COVID-19.

CovalX Technology Used

Epitope Mapping

Source

Contact our Scientific Team to Start the Conversation

Request A Call
Categories : Patents, Epitope Mapping
CovalX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.